Showing results (11-20 of 495) with videos related to
Sort By:
Pageof 50
Hepato-Gastroenterology|May 31, 2001
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradicationS Danese, A Armuzzi, A Romano, et al.The American Journal of Gastroenterology|September 25, 2001
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel diseaseA Papa, V De Stefano, S Danese, et al.Scandinavian Journal of Gastroenterology|May 7, 2002
Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosaA Papa, S Danese, A Sgambato, et al.Gastroenterologie Clinique Et Biologique|February 2, 2010
New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?S Danese, E AngelucciCurrent Medicinal Chemistry|March 10, 2007
The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunityS Danese, S RutellaOncogene|April 20, 2010
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancerS Danese, A MantovaniScandinavian Journal of Gastroenterology|April 18, 2001
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosaS Danese, F Cremonini, A Armuzzi, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 1999
Autoimmune diseases and Helicobacter pylori infectionA Gasbarrini, F FranceschiEuropean Review for Medical and Pharmacological Sciences|January 14, 2017
The healthcare service in Italy: regional variabilityA Cicchetti, A GasbarriniEuropean Review for Medical and Pharmacological Sciences|February 24, 2006
Early atherosclerosis in patients with inflammatory bowel diseaseA Papa, S Danese, R Urgesi, et al.Pageof 50